BBOT to Participate in the Jefferies Global Healthcare Conference in London GlobeNewswire November 03, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the […]

Superior Group of Companies Reports Third Quarter 2025 Results GlobeNewswire November 03, 2025 – Total net sales of $138.5 million, compared to $149.7 million in prior year third quarter – – Net income of $2.7 million, compared to $5.4 million in prior year third quarter – – EBITDA of $7.5 million, compared to $11.7 million

Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call GlobeNewswire November 03, 2025 CINCINNATI, Nov. 03, 2025 (GLOBE NEWSWIRE) — Mobile Infrastructure Corporation (NASDAQ: BEEP), the nation's only publicly traded owner of parking infrastructure, will issue its third quarter 2025 earnings release after the U.S. market closes on Monday, November 10,

Pyxis Oncology to Participate in Upcoming Investor Conferences GlobeNewswire November 03, 2025 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will participate in the following upcoming investor conferences in November 2025: Guggenheim 2nd Annual Healthcare Innovation Conference, Boston,

BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors GlobeNewswire November 03, 2025 LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment

Regeneron Announces Investor Conference Presentations GlobeNewswire November 03, 2025 TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Jefferies London Healthcare Conference at 3:30 p.m. GMT (10:30 a.m. ET) on Monday, November 17, 2025 7th Annual Wolfe Research Healthcare Conference at 9:20 a.m. ET on

InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer GlobeNewswire November 03, 2025 DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri,

Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline – MLTX GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks

Investors who lost money on RCI Hospitality Holdings, Inc. (RICK) should contact Levi & Korsinsky about pending Class Action – RICK GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in RCI Hospitality Holdings, Inc. (“RCI Hospitality Holdings, Inc.” or the “Company”) (NASDAQ: RICK) of a

Lost Money on aTyr Pharma, Inc. (ATYR)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) of a class action securities lawsuit. CLASS DEFINITION: The